✦ LIBER ✦

Long-term outcomes of distant metastasis from differentiated thyroid carcinoma

✍ Scribed by I-Chin Huang; Feng-Fu Chou; Rue-Tsuan Liu; Shih-Chen Tung; Jung-Fu Chen; Ming-Chun Kuo; Ching-Jung Hsieh; Pei-Wen Wang

Book ID: 108705071
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 122 KB
Volume: 76
Category: Article
ISSN: 0300-0664
DOI: 10.1111/j.1365-2265.2011.04231.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinico-pathological Characteristics and

Clinico-pathological Characteristics and Long-term Outcome in Patients with Distant Metastases from Differentiated Thyroid Carcinoma

✍ Carlos A. Benbassat; Sara Mechlis-Frish; Dania Hirsch 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 49 KB

Clinico-Pathological Characteristics and

Clinico-Pathological Characteristics and Long-term Outcome in Patients with Distant Metastases from Differentiated Thyroid Carcinoma

✍ Vivek Aggarwal; P. R. K. Bhargav; Anjali Mishra; Gaurav Agarwal 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 49 KB

MRI Detection of Cervical Metastasis Fro

MRI Detection of Cervical Metastasis From Differentiated Thyroid Carcinoma

✍ Neil D. Gross; Jane L. Weissman; J. Michael Talbot; Peter E. Andersen; Mark K. W 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 291 KB

Clinicopathological Characteristics and

Clinicopathological Characteristics and Long-term Outcome in Patients with Distant Metastases from Differentiated Thyroid Cancer

✍ Carlos A. Benbassat; Sara Mechlis-Frish; Dania Hirsch 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 232 KB

Long-Term Outcome of Differentiated Thyr

Long-Term Outcome of Differentiated Thyroid Carcinoma: Experience in a Developing Country

✍ Panchagan Rama Kant Bhargav; Anjali Mishra; Gaurav Agarwal; Amit Agarwal; Prasan 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 233 KB

Adjuvant therapy and long-term managemen

Adjuvant therapy and long-term management of differentiated thyroid carcinoma

✍ Steven I. Sherman 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 28 KB 👁 1 views

As with most therapies for differentiated thyroid carcinoma, there is little consensus about optimal use of postoperative adjuvant therapies or long-term follow-up strategies. However, an increasing body of data indicates that most patients can benefit from postoperative radioiodine ablation followe